Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 89.40
+3.10 (3.59%)
May 28, 2026, 5:35 PM CET
Pharmanutra Revenue
Pharmanutra had revenue of 33.40M EUR in the quarter ending March 31, 2026, with 24.51% growth. This brings the company's revenue in the last twelve months to 138.73M, up 16.65% year-over-year. In the year 2025, Pharmanutra had annual revenue of 132.16M with 13.78% growth.
Revenue (ttm)
138.73M
Revenue Growth
+16.65%
P/S Ratio
6.17
Revenue / Employee
1.08M
Employees
128
Market Cap
856.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 132.16M | 16.01M | 13.78% |
| Dec 31, 2024 | 116.15M | 15.44M | 15.33% |
| Dec 31, 2023 | 100.71M | 17.64M | 21.24% |
| Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
| Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| Safilo Group | 983.38M |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Philogen | 319.73M |
Pharmanutra News
- 17 days ago - Pharmanutra Earnings release: Q1 2026 - Filings
- 17 days ago - Pharmanutra Slides: Q1 2026 - Filings
- 17 days ago - Pharmanutra Quarterly report: Q1 2026 - Filings